Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$57.49 -0.95 (-1.63%)
As of: Oct 2, 2026 · 3:46 PM EDT

Biomarin Pharmaceutical (BMRN) Long-Term Investments (2009 - 2025)

Updated

Biomarin Pharmaceutical's Long-Term Investments was $492.24 million in Q4 2025, down 5.6% from $521.24 million a year earlier and down 4.0% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Long-Term Investments (2009 - 2025) Analysis & Trends

From Q4 2009 onward, Biomarin Pharmaceutical has reported Long-Term Investments for 64 quarters.

  • Long-Term Investments shows a five-year compound annual growth rate of 11.5% (FY2020 to FY2025).
  • In earlier years, Long-Term Investments was $521.24 million in FY2024 (-14.7%), $611.14 million in FY2023 (+83.1%), $333.84 million in FY2022 (-34.3%) and $507.79 million in FY2021 (+77.9%).
  • The Q4 2025 figure marks the lowest quarterly Long-Term Investments since Q2 2023.
  • Compared with a year earlier, Long-Term Investments has declined for five straight quarters, with growth averaging 9.1% over the last eight quarters.
  • The best year-over-year quarter for Long-Term Investments over five years was Q4 2023 (growth of 83.1%); the worst was Q4 2022 (a decline of 34.3%).
  • Per Business Quant data, BMRN's Long-Term Investments in the three quarters before Q4 2025 was $512.94 million (Q3 2025), $508.59 million (Q2 2025) and $506.72 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Biomarin Pharmaceutical 11.61 Bn 5.48 Bn 786.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 492.24 Mn
Sep 30, 2025 512.94 Mn
Jun 30, 2025 508.59 Mn
Mar 31, 2025 506.72 Mn
Dec 31, 2024 521.24 Mn
Sep 30, 2024 561.99 Mn
Jun 30, 2024 557.08 Mn
Mar 31, 2024 620.55 Mn
Dec 31, 2023 611.14 Mn
Sep 30, 2023 548.00 Mn
Jun 30, 2023 385.78 Mn
Mar 31, 2023 340.64 Mn
Dec 31, 2022 333.84 Mn
Sep 30, 2022 372.30 Mn
Jun 30, 2022 412.50 Mn
Mar 31, 2022 462.83 Mn
Dec 31, 2021 507.79 Mn
Sep 30, 2021 466.62 Mn
Jun 30, 2021 350.24 Mn
Mar 31, 2021 321.13 Mn
API Access

Biomarin Pharmaceutical Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=BMRN&period=max&api_key=YOUR_API_KEY